Agex Therapeutics, Inc.
AGECIK 0001708599 · Every Form 4 filed by insiders at this issuer. See financials →
Annual report (10-K)
Latest 10-K/A filed Mar 27, 2026. Sentiment + YoY language diff vs prior year. Read sections →
Signal:NeutralFull-doc fallback
Full filing:tone -0.0097
Sentiment via Loughran-McDonald lexicon · YoY diff via Jaccard similarity + paragraph set difference.
Recent 8-K announcements
Per-item disclosure feed. Item 2.02 is the earnings release.
May 14, 2026no items parsedApr 21, 2026no items parsedMar 25, 2026no items parsedMar 23, 20261.01 · Entry into a Material Definitive Agreeme3.02 · Unregistered Sales5.02 · Departure/Election5.03 · Amendments to Articles7.01 · Regulation FD Disclosure9.01 · Financial Statements and ExhibitsJan 28, 2026no items parsed
Top insiders
Most active reporters at Agex Therapeutics, Inc.
| Name | Roles | Filings |
|---|---|---|
| Venkatesan Jay | Director | 4 |
| Marshall Richard Peter | Director | 3 |
| Tenjarla Srini | Officer | 3 |
| West Michael D | OfficerDirector | 3 |
| Wilson Karen J | Director | 3 |
Top performers
Insiders ranked by realized 90-day signed return on their open-market trades at Agex Therapeutics, Inc.. Minimum 3 scored trades. Returns are signed - a sale followed by a rally counts against the insider.
| # | Insider | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|---|
| 1 | Moreadith Randall | 31 | 94% | +32.6% | +37.1% | +59.8% | -25.0% |
| 2 | Mintz Steven | 14 | 7% | -20.6% | -22.3% | +2.6% | -27.7% |
| 3 | Bailey Gregory | 16 | 6% | -19.6% | -18.1% | +2.9% | -39.4% |
All filings
95 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|